核医学实验室对新型冠状病毒肺炎疫情中、高风险地区患者血液标本的管理探索  

Exploration on management of blood samples from patients in intermediate and high risk areas of COVID-19 epidemic period in nuclear medicine laboratory

作　　者：傅鹏[1] 吴炜杰[1] 高建青[1] 魏玲格[1] Fu Peng;Wu Weijie;Gao Jianqing;Wei Lingge(Department of Nuclear Medicine,the Third Hospital of Hebei Medical University,Shijiazhuang 050051,China)

机构地区：[1]河北医科大学第三医院核医学科,石家庄050051

出　　处：《国际放射医学核医学杂志》2022年第8期502-505,共4页International Journal of Radiation Medicine and Nuclear Medicine

摘　　要：目前,新型冠状病毒肺炎仍是全世界感染防控的重点,在我国有效实施防控措施的情况下,总体已基本得到控制,但随着疫情的持续发展,仍存在小规模爆发事件。笔者在疫情防控期间,从工作实践角度出发,初步探讨了非定点医院核医学科体外分析实验室对中、高风险地区患者血液标本的管理,旨在为全国核医学实验室相关工作人员提供一定的参考和建议,以有效阻断病毒传播途径,避免院内交叉感染。COVID-19 is still the focus of infection prevention and control in the world at present,and has been achieved general basic control under the effective implementation of prevention and control measures in China.However,with the continuous development of the epidemic,there are still small-scale outbreaks.From the perspective of work practice during the COVID-19 epidemic period,the authors preliminarily discussed the management of blood samples from intermediate and high-risk areas in the vitro analysis laboratory of nuclear medicine department in non-designated hospital.The aim of this study is to provide some experience and suggestions for the relevant staff of nuclear medicine laboratories in China,so as to effectively block the transmission route of virus and avoid nosocomial cross infection.

关 键 词：新型冠状病毒肺炎 感染控制 实验室 核医学科 血液标本 

分 类 号：R563.1[医药卫生—呼吸系统]